ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model
Clinical Validation of the Brain Model Published Online in the Journal NeuroImage ClearPoint Maestro Brain Model ClearPoint Maestro Brain Model ClearPoint Neuro Maestro Brain Model Comparative Reproducibility Error Results Reproducibility error of Maestro (green), FreeSurfer 7.2 (blue) and manual segmentation (red) for common brain structures (left), and average over all structures (right). Bars represent range of measured relative volume difference. SOLANA BEACH, Calif., Feb. 21, 2024 (GLOBE NE
Clinical Validation of the Brain Model Published Online in the Journal NeuroImage ClearPoint Maestro Brain Model ClearPoint Maestro Brain Model ClearPoint
ClearPoint Neuro, Inc. on LinkedIn: Finalists Announced - CEO of the Year Awards 2022
SNN
ClearPoint Neuro, Inc. on LinkedIn: #clearpoint #smartflow #clpt #genetherapy #clinicaltrials
SNN
ClearPointNeuro (@ClearPointNeuro) / X
Taiwan FDA clears Brain Navi's autonomous neurosurgical navigation robot
SNN
SNN
Press Releases :: ClearPoint Neuro, Inc. (CLPT)
ClearPoint Neuro, Inc. Announces First Procedure Utilizing ClearPoint® 2.0 Software in Europe
Stock Market News 2024-02-21
SNN
